Utilizing the PRINT® NANOTECHNOLOGY PLATFORM to develop PRECISELY ENGINEERED particles for DRUG DELIVERY and films for MATERIALS SCIENCE applications
PRINT® Technology
Liquidia utilizes a proprietary PRINT technology platform to design and manufacture highly precise micro- and nanoparticles and patterned films for applications in the life and materials science sectors. PRINT technology combines the precision of the microelectronics industry with the scalability of films manufacturing to produce custom shape and size-specific nanomaterials.

Life Sciences - Redefining Engineered Delivery
In the life sciences sector, Liquidia is using PRINT technology to develop Engineered Drug Therapies™ - precisely engineered micro- and nanoparticles - for the delivery of biological and small molecule therapeutics. Initial programs include siRNA delivery, inhaled therapeutics, and vaccines. Liquidia's ability to customize the shape, size, surface functionalization, and composition of particles enables increased efficacy of therapeutics.

Materials Science - Nano-Patterned Films for Light Managemen
Within the materials science sector, Liquidia is developing nano-patterned films for displays, solid state lighting, photovoltaics and related applications. The ability to replicate complex structures with nanometer fidelity, from a range of materials, and in a cost-effective manner will enable brighter, more energy efficient films and products for Liquidia's partners and consumers.
Recent News

June 22, 2009 - Liquidia presents at AAPS National Biotechnology Conference.  Details

June 11, 2009 - Liquidia appoints Dr. Thomas Templeman as SVP  Details

April 28, 2009 - Liquidia presents data at NFID Conference on Vaccines Research  Details

January 7, 2009 - Liquidia Announces Collaboration with Abbott to Develop siRNA Therapeutics  Details

January 2009 - Liquidia to present at SPIE Photonics West in San Jose, CA

December 28, 2008 - Liquidia founder named 'Tar Heel of the Year'  Details

October 30, 2008 - Liquidia to present at FPD International Forum in Yokohama, Japan  Details

August 6, 2008 - Shape is key in nanomedicine  Details

July 14, 2008 - Liquidia presents at Controlled Release Society Annual Meeting  Details

June 25, 2008 - $500,000 Lemelson-MIT Prize awarded to Liquidia founder  Details


HOME      |      ABOUT US       |      TECHNOLOGY      |      PARTNERSHIPS      |      MEDIA ROOM      |      CAREERS      |      CONTACT
Copyright 2008 © Liquidia. All rights reserved.